Preferred Label : thienopyridine;

MeSH note : patients were treated with thienopyridine after percutaneous coronary intervention;

Is substance : O;

Détails


Position du mot-clé dans l'(les) arborescence(s) : arborescence

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


http://www.pharmactuel.com/index.php/pharmactuel/article/view/1065/850
2016
false
false
false
false
Canada
French
drug administration schedule
drug administration schedule
critical appraisal or critical reading
critical appraisal or critical reading
Drug-Eluting stents
Drug-Eluting stents
drug therapy, combination
drug therapy, combination
multicenter studies as topic
multicenter studies as topic
thrombosis
thrombosis
aspirin
aspirin
aspirin
aspirin
Prasugrel Hydrochloride
Prasugrel Hydrochloride
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
thienopyridine
thienopyridine
platelet aggregation inhibitors
platelet aggregation inhibitors
Drug-eluting coronary stent placement
Drug-eluting coronary stent placement
hemorrhage
hemorrhage
Coronary stent thrombosis
Coronary stent thrombosis
thienopyridine
thienopyridine
stroke
stroke
myocardial infarction
myocardial infarction
time
time
platelet aggregation inhibitors
platelet aggregation inhibitors
pyridines
pyridines
pyridines
pyridines
Clopidogrel
Clopidogrel

---
Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.